Home
News
Create
Screeners
Insights
Zenotech Laboratories
40.
40
-1.57
(-3.74%)
Market Cap
₹246.52 Cr
PE Ratio
77.72
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-3.74%
1M
-13.23%
6M
-27.36%
1Y
-25.78%
5Y
+10.68%
View Company Insights
Latest news about Zenotech Laboratories
Zenotech Laboratories Files BSE Report on Independent Director Appointment with 99.90% Approval
2 days ago
Zenotech Laboratories officially filed comprehensive postal ballot results with BSE Limited, confirming the successful appointment of Mr. Nikkhil Venilal Kothhari as Independent Director with overwhelming 99.90% shareholder approval. The filing included detailed voting breakdown showing participation from 68 members representing 69.12% of total shareholding, complete regulatory compliance documentation, and scrutinizer's report, reinforcing the company's commitment to transparent corporate governance practices.
Zenotech Laboratories Reports Q3FY26 Results and Announces Key Board Changes
Jan 23, 2026
Zenotech Laboratories Reports Mixed Q2 Results with Revenue Growth and Net Loss
Oct 31, 2025
Zenotech Laboratories Reports Q1 Results, Appoints New Statutory Auditors
Jul 28, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO